<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(4)</volume><submitter>Baum M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>MRSA is a major global healthcare problem. In 2011, a new &lt;i>mec&lt;/i> variant designated &lt;i>mecC&lt;/i> was described, presenting partial identity at the DNA level, thus undetectable by routine &lt;i>mecA&lt;/i> PCR.&lt;h4>Objectives&lt;/h4>Until now, no reliable information regarding &lt;i>mecC&lt;/i> MRSA prevalence was available in Israel. In this study, to the best of our knowledge, we describe the first case of &lt;i>mecC&lt;/i> MRSA in Israel, with focus on genomic analysis and global context.&lt;h4>Methods&lt;/h4>The &lt;i>mecC&lt;/i> MRSA isolate was analysed by WGS with focus on phylogeny, global contextualization, virulence and resistance genes. The strain was characterized by antibiotic susceptibility testing, &lt;i>spa&lt;/i> typing and presence of &lt;i>mecA/C&lt;/i> and &lt;i>pvl&lt;/i> genes.&lt;h4>Results&lt;/h4>An MR</pubmed_abstract><journal>JAC-antimicrobial resistance</journal><pagination>dlac085</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9418563</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>mecC&lt;/i> MRSA in Israel-genomic analysis, prevalence and global perspective.</pubmed_title><pmcid>PMC9418563</pmcid><pubmed_authors>Prajgrod G</pubmed_authors><pubmed_authors>Valinsky L</pubmed_authors><pubmed_authors>Baum M</pubmed_authors><pubmed_authors>Rokney A</pubmed_authors><pubmed_authors>Anuka E</pubmed_authors><pubmed_authors>Treygerman O</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>mecC&lt;/i> MRSA in Israel-genomic analysis, prevalence and global perspective.</name><description>&lt;h4>Background&lt;/h4>MRSA is a major global healthcare problem. In 2011, a new &lt;i>mec&lt;/i> variant designated &lt;i>mecC&lt;/i> was described, presenting partial identity at the DNA level, thus undetectable by routine &lt;i>mecA&lt;/i> PCR.&lt;h4>Objectives&lt;/h4>Until now, no reliable information regarding &lt;i>mecC&lt;/i> MRSA prevalence was available in Israel. In this study, to the best of our knowledge, we describe the first case of &lt;i>mecC&lt;/i> MRSA in Israel, with focus on genomic analysis and global context.&lt;h4>Methods&lt;/h4>The &lt;i>mecC&lt;/i> MRSA isolate was analysed by WGS with focus on phylogeny, global contextualization, virulence and resistance genes. The strain was characterized by antibiotic susceptibility testing, &lt;i>spa&lt;/i> typing and presence of &lt;i>mecA/C&lt;/i> and &lt;i>pvl&lt;/i> genes.&lt;h4>Results&lt;/h4>An MR</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-05T00:42:36.574Z</modification><creation>2025-02-19T03:29:06.119Z</creation></dates><accession>S-EPMC9418563</accession><cross_references><pubmed>36042980</pubmed><doi>10.1093/jacamr/dlac085</doi></cross_references></HashMap>